Primary Evans Syndrome (ES)
1 clinical trials · Condition
◉ Watch Primary Evans Syndrome (ES)
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) (NCT07421167) | Novartis Pharmaceuticals | 2026-08-04 |
Track Primary Evans Syndrome (ES) automatically
Every clearance here is in the API, with alerts when new ones post.